Title |
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
|
---|---|
Published in |
Frontiers in Pharmacology, November 2015
|
DOI | 10.3389/fphar.2015.00279 |
Pubmed ID | |
Authors |
Anne-Florence Blandin, Guillaume Renner, Maxime Lehmann, Isabelle Lelong-Rebel, Sophie Martin, Monique Dontenwill |
Abstract |
Integrins belong to a large family of αβ heterodimeric transmembrane proteins first recognized as adhesion molecules that bind to dedicated elements of the extracellular matrix and also to other surrounding cells. As important sensors of the cell microenvironment, they regulate numerous signaling pathways in response to structural variations of the extracellular matrix. Biochemical and biomechanical cues provided by this matrix and transmitted to cells via integrins are critically modified in tumoral settings. Integrins repertoire are subjected to expression level modifications, in tumor cells, and in surrounding cancer-associated cells, implicated in tumor initiation and progression as well. As critical players in numerous cancer hallmarks, defined by Hanahan and Weinberg (2011), integrins represent pertinent therapeutic targets. We will briefly summarize here our current knowledge about integrin implications in those different hallmarks focusing primarily on β1 integrins. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 25% |
Switzerland | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
Netherlands | 1 | <1% |
Italy | 1 | <1% |
United Kingdom | 1 | <1% |
Denmark | 1 | <1% |
Unknown | 141 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 31 | 21% |
Student > Bachelor | 21 | 14% |
Researcher | 19 | 13% |
Student > Doctoral Student | 17 | 12% |
Student > Master | 14 | 10% |
Other | 14 | 10% |
Unknown | 30 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 39 | 27% |
Agricultural and Biological Sciences | 33 | 23% |
Medicine and Dentistry | 16 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
Engineering | 4 | 3% |
Other | 17 | 12% |
Unknown | 31 | 21% |